Download Files:
Products Details
Product Description
– EGFR-IN-29 is a potent EGFR inhibitor, example J-022, extracted from Patent WO2021160087[1].
Web ID
– HY-143729
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C36H46BrN8O2P
References
– [1]Xiangyong Liu. Quinolyl phosphine oxide compound, and composition and application thereof. Patent WO2021160087.
CAS Number
– 2682200-93-5
Molecular Weight
– 733.68
SMILES
– O=P(C)(C)C1=C2C=CC(C3CC3)=NC2=CC=C1NC4=NC(NC5=C(OC)C=C(N6CCC(CC6)N7CCN(CC7)C)C(C)=C5)=NC=C4Br
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– EGFR
Isoform
– EGFR/ErbB1/HER1
Pathway
– JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
